Long-Term Followup and/or Thalidomide Maintenance Therapy for Patients Enrolled on Clinical Trial 20030165

NCT02507336 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Mantle Cell Lymphoma
Non-Hodgkin's Lymphoma

Interventions

DRUG: Thalidomide

Sponsor

University of Miami